These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15034704)

  • 21. Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin.
    Varma MV; Lin J; Bi YA; Rotter CJ; Fahmi OA; Lam JL; El-Kattan AF; Goosen TC; Lai Y
    Drug Metab Dispos; 2013 May; 41(5):966-74. PubMed ID: 23393219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism.
    Kalliokoski A; Backman JT; Kurkinen KJ; Neuvonen PJ; Niemi M
    Clin Pharmacol Ther; 2008 Oct; 84(4):488-96. PubMed ID: 19238654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo.
    Tornio A; Niemi M; Neuvonen M; Laitila J; Kalliokoski A; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2008 Sep; 84(3):403-11. PubMed ID: 18388877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
    Kalliokoski A; Neuvonen M; Neuvonen PJ; Niemi M
    J Clin Pharmacol; 2008 Mar; 48(3):311-21. PubMed ID: 18187595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine.
    Li C; Choi DH; Choi JS
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):99-108. PubMed ID: 22210483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.
    Fan L; Zhou G; Guo D; Liu YL; Chen WQ; Liu ZQ; Tan ZR; Sheng D; Zhou HH; Zhang W
    Clin Pharmacokinet; 2011 Sep; 50(9):605-11. PubMed ID: 21827215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
    Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
    Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP3A4 genetic polymorphism influences repaglinide's pharmacokinetics.
    Ruzilawati AB; Gan SH
    Pharmacology; 2010; 85(6):357-64. PubMed ID: 20523106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PXR polymorphisms and their impact on pharmacokinetics/pharmacodynamics of repaglinide in healthy Chinese volunteers.
    Du QQ; Wang ZJ; He L; Jiang XH; Wang L
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1917-25. PubMed ID: 23807564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic drug interactions with vandetanib during coadministration with rifampicin or itraconazole.
    Martin P; Oliver S; Robertson J; Kennedy SJ; Read J; Duvauchelle T
    Drugs R D; 2011; 11(1):37-51. PubMed ID: 21410294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism-based inactivation of CYP2C8 by gemfibrozil occurs rapidly in humans.
    Honkalammi J; Niemi M; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2011 Apr; 89(4):579-86. PubMed ID: 21368757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent interaction between gemfibrozil and repaglinide in humans: strong inhibition of CYP2C8 with subtherapeutic gemfibrozil doses.
    Honkalammi J; Niemi M; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2011 Oct; 39(10):1977-86. PubMed ID: 21778352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of MDR1 G2677T/a genetic polymorphisms on the pharmacokinetics of repaglinide in healthy Chinese volunteers.
    Xiang Q; Cui YM; Zhao X; Yan L; Zhou Y
    Pharmacology; 2012; 89(1-2):105-10. PubMed ID: 22398664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers.
    He J; Qiu Z; Li N; Yu Y; Lu Y; Han D; Li T; Zhao D; Sun W; Fang F; Zheng J; Fan H; Chen X
    Eur J Clin Pharmacol; 2011 Jul; 67(7):701-7. PubMed ID: 21327909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
    Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.
    Niemi M; Backman JT; Juntti-Patinen L; Neuvonen M; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Aug; 60(2):208-17. PubMed ID: 16042675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L; Bundgaard C; Garmer M; Jensen B
    Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.